Choosing metoprolol or carvedilol in heart failure (a pre-COMET commentary).
Rajput
Farzan S
FS
Drexel University College of Medicine, Philadelphia, PA, USA. fsr22@drexel.edu
Gnanasekeram
Hari
H
Satwani
Shiyam
S
Davenport
James D
JD
Gracely
Edward J
EJ
Gopalan
Radha
R
Narula
Jagat
J
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use*; D000077261:Carvedilol; D002986:Clinical Trials as Topic; D015444:Exercise / Q000502:physiology; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology*; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D008790:Metoprolol / Q000627:therapeutic use*; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D018579:Patient Selection; D011412:Propanolamines / Q000627:therapeutic use*; D012146:Rest / Q000502:physiology; D012189:Retrospective Studies
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol; D008790:Metoprolol